logo

For the Inventor, By the Inventor

Bothell, WA, United States of America

Cocrystal Pharma, Inc.


USPTO Granted Patents = 18

% Expired Patents = 22.2


Forward Citations = 50

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Irina C Jacobson (11 out of 27 patents)

silverMedal Steven J Coats (7 out of 27 patents)

bronzeMedal Raymond F Schinazi (6 out of 124 patents)

4.  Michael David Feese (5 out of 7 patents)

5.  Sam S K Lee (5 out of 6 patents)

6.  Franck Amblard (5 out of 15 patents)

7.  Sam S Lee (4 out of 4 patents)

8.  Hongwang Zhang (4 out of 7 patents)

9.  Longhu Zhou (4 out of 8 patents)

10.  Richard Anthony Whitaker (3 out of 8 patents)

11.  Tamara Rosario McBrayer (3 out of 5 patents)

12.  Junxing Shi (3 out of 23 patents)

13.  Biing Yuan Lin (3 out of 3 patents)

14.  Wang Shen (1 out of 45 patents)

15.  Xiaoling Zheng (1 out of 11 patents)


18 patents:

1. 12649715 - Inhibitors of norovirus and coronavirus replication (2026-06-09),
2. 12565488 - Inhibitors of influenza virus replication (2026-03-03),
3. 12357631 - Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replication (2025-07-15),
4. 12233066 - Combinations of inhibitors of influenza virus replication (2025-02-25),
5. 12156876 - Formulations of influenza therapeutics (2024-12-03),
6. 12037333 - Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication (2024-07-16),
7. 11752166 - Combination therapy for treatment of HCV (2023-09-12),
8. 11014941 - Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication (2021-05-25),
9. 10947210 - Inhibitors of Hepatitis C virus polymerase (2021-03-16),
10. 10464914 - Inhibitors of hepatitis C virus polymerase (2019-11-05),
11. 10426762 - Inhibitors of hepatitis C virus polymerase (2019-10-01),
12. 10011629 - Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer (2018-07-03),
13. 9932326 - Potent and selective inhibitors of hepatitis C virus (2018-04-03),
14. 9926295 - Potent and selective inhibitors of hepatitis C virus (2018-03-27),
15. 9809616 - Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer (2017-11-07),
Company Overview
Cocrystal Pharma, Inc. is a biotechnology company based in Bothell, Washington, focused on the discovery and development of novel antiviral therapeutics. The company specializes in utilizing its proprietary platform technology to design and develop innovative treatments targeting viral infections, including those caused by influenza and coronaviruses. Cocrystal's research emphasizes the application of advanced molecular biology techniques to create effective antiviral agents, aiming to address significant unmet medical needs in infectious diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Cocrystal Pharma, Inc. USPTO Patent Assignee Logo
18 Patents

#30 in Bothell, WA

#385 in Washington

#17,963 in US

#34,217 in the World

Bothell, WA (US)
Bothell, WA, United States of America

Cocrystal Pharma, Inc.

Forward Citations = 50

40 inventors:

goldMedal Irina C Jacobson (11 out of 27 patents)

silverMedal Steven J Coats (7 out of 27 patents)

bronzeMedal Raymond F Schinazi (6 out of 124 patents)

4.  Michael David Feese (5 out of 7 patents)

5.  Sam S K Lee (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cocrystal Pharma, Inc.. Retrieved from https://idiyas.com/company/cocrystal-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…